Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for GRML.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2022. Start Trial.
Date Value
June 30, 2026 57.90M
March 31, 2026 51.47M
December 31, 2025 9.464M
September 30, 2025 9.927M
June 30, 2025 10.65M
March 31, 2025 0.6387M
December 31, 2024 1.185M
September 30, 2024 1.461M
June 30, 2024 -1.551M
Date Value
March 31, 2024 11.09M
December 31, 2023 0.5717M
September 30, 2023 50.77M
June 30, 2023 50.48M
March 31, 2023 50.64M
December 31, 2022 113.32M
September 30, 2022 112.60M
June 30, 2022 111.87M
March 31, 2022 0.0164M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. 113.59M
Manhattan Scientifics, Inc. --
Exicure, Inc. 0.977M
Century Therapeutics, Inc. 232.34M
Absci Corp. 246.13M

Shareholders Equity (Quarterly) Related Metrics